Liquid biopsy companies develop minimally invasive tests that analyse tumour-derived and other disease-associated material found in blood or bodily fluids. These technologies support earlier detection, treatment selection, response monitoring and the identification of disease recurrence.
This category includes companies working on:
Browse 33 UK liquid biopsy companies below.
Decentralised molecular and multiomic diagnostics as a service
Molomix Bioscience is a Welsh biotechnology company providing decentralised molecular and multiomic diagnostics for research, clinical and applied testing settings. The company…
Benchtop super-resolution microscopes for single-molecule biological imaging
Oxford Nanoimaging (ONI) is an Oxford-based manufacturer of compact super-resolution fluorescence microscopes and consumable application kits for life science research. Its…
GCP-accredited oncology molecular diagnostics for clinical trials and research
The Cancer Molecular Diagnostics Laboratory is an ISO 15189-accredited molecular diagnostics facility within the University of Cambridge Department of Oncology, jointly funded by…
Contract proteomics CRO and inventor of TMT isobaric mass tags
Proteome Sciences is a contract proteomics organisation and reagent manufacturer specialising in mass spectrometry-based protein biomarker discovery, validation, and targeted…
Non-invasive oral cancer screening using genomics and cell-free DNA
Wisdom Bioscience is a biotechnology company developing a non-invasive oral cancer screening platform that integrates next-generation sequencing and cell-free DNA analysis with…
Solutions for genomics, diagnostics and precision medicine
QIAGEN is a global provider of sample preparation, molecular diagnostics, and genomics solutions for pharmaceutical, clinical, and research applications. Its UK headquarters at…
Liquid biopsy NGS kits and genomic diagnostic services
Nonacus is a developer of next-generation sequencing reagents and library preparation kits for liquid biopsy and tissue-based genomic analysis. Its target enrichment and cell-free…
Infrared spectroscopy blood test for early multi-cancer detection
Dxcover is a clinical-stage biotechnology company developing a blood-based multi-cancer early detection test. Its platform applies infrared spectroscopy to a dried blood spot to…
RNA sequencing liquid biopsy for cardiovascular and complex disease screening
MultiplAI Health is a Cambridge biotech developing a whole-blood RNA sequencing test for early screening of cardiovascular and other complex diseases. Its platform combines…
Integrated NGS assays for genomic profiling of haematological malignancies
Univ8 Genomics is a Belfast-based genomics diagnostics company developing targeted next-generation sequencing assays for the integrated clinical characterisation of haematological…
Proteomics and AI liquid biopsy for early lung cancer detection
Oxford Cancer Analytics is a biotechnology company developing blood-based diagnostic tests for early cancer detection using high-throughput circulating proteome analysis and…
Blood-based liquid biopsy for endothelial glycocalyx and microvascular health
Dimension Biotechnologies is a biotech developing a rapid, blood-based diagnostic for microvascular health based on analysis of the endothelial glycocalyx, the molecular layer…